NCT07453394 2026-03-06
QLS5132 Combination Therapy in Advanced Solid Tumors
Qilu Pharmaceutical Co., Ltd.
Phase 1/2 Not yet recruiting
Qilu Pharmaceutical Co., Ltd.
Tyligand Pharmaceuticals (Suzhou) Limited
ImmunityBio, Inc.
Cantargia AB
Incyte Corporation